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P U B L I S H E D B Y E L S E V I E R I N C .LettersBreast Arterial
Calciﬁcations and Their
Association With Incident
Cardiovascular Disease
and Diabetes
The Prospect-EPIC CohortBreast arterial calciﬁcations (BACs), which are a type
of medial calciﬁcation, are prevalent among diabetes
patients and are believed to be associated with
increased cardiovascular risk. However, longitudinal
studies that have examined BACs are scarce. We
aimed to investigate the association of BACs with
incident cardiovascular disease (CVD) and type 2
diabetes (T2D).
We performed a series of case–cohort studies
nested within the larger Prospect-EPIC (European
Prospective Investigation into Cancer and Nutrition)
cohort study (n ¼ 17,357) (1). Expert radiologists
scored BACs on baseline ﬁlm mammograms as ab-
sent, mild, moderate, or severe. The between-
observers Cohen’s kappa was 0.48 (95% conﬁdence
interval [CI]: 0.37 to 0.59) for BAC presence and/or
absence, and the kappa with linear weighting for all
4 categories was 0.53 (95% CI: 0.46 to 0.61) in a
sample of 240 mammograms. To obtain vital status,
causes of death, and hospital discharge diagnoses,
16,737 women gave consent for database linkage
purposes. During a median follow-up of 13.2 years
(interquartile range: 12.2 to 14.2 years), incident
cases of coronary heart disease (CHD) (n ¼ 1,050),
stroke (n ¼ 398), peripheral artery disease (PAD) (n ¼
257), and T2D (n ¼ 526) were documented. These
cases were compared with a 10% random subcohort
(n ¼ 1,672) drawn from the baseline. A combined
endpoint of CHD, stroke, and PAD (n ¼ 1,551) was
also investigated. For the analysis of incident T2D,
women with prevalent diabetes were excluded.
Hazard ratios (HRs) and 95% CIs were obtained from
Cox proportional hazards models adapted to the
case–cohort design through Prentice weighting.
Multiple imputation techniques were used to handle
missing baseline data.Of the women in the subcohort with available
mammograms (n ¼ 1,540), 133 (8.6%) had BACs,
which were mild in 75 (4.9%), moderate in 39 (2.5%),
or severe in 19 (1.2%) women. Women with BACs
tended to be older; they had hypertension more
often, smoked less often, had more children, were
more often postmenopausal, drank less alcohol, had
lower glomerular ﬁltration rates, and used hormone
replacement therapy less often.
The presence of BAC was signiﬁcantly associated
with CHD (HR: 1.44; 95% CI: 1.02 to 2.01) and
combined CVD (HR: 1.39; 95% CI: 1.00 to 1.93)
(Table 1). HRs for stroke and PAD were similar, but
were nonsigniﬁcant. Larger effect sizes were found
for severe BAC, with HRs of 3.37 (95% CI: 1.80 to
6.31) for combined CVD, 3.40 (95% CI: 1.76 to 6.57)
for CHD, 2.85 (95% CI: 1.32 to 6.15) for stroke, and
2.93 (95% CI: 1.05 to 8.16) for PAD compared with
women without BACs. Part of these effects could be
attributable to pulse pressure, especially for stroke
and PAD, because of the difference in HRs between
models 2 and 3. No associations were found between
BAC and T2D.
The strengths of this study included its large
sample size and long follow-up, which provided suf-
ﬁcient events for multivariable analysis. A limitation
is that we used ﬁlm mammography from the 1990s,
and that BAC scoring is subjective. Current technol-
ogy and automatic quantiﬁcation of BACs might
possibly show stronger effects. Two limitations
inherent to our design were that confounder data
were limited to the cross sectionally gathered infor-
mation at baseline and the potential for residual
confounding.
Our results are in line with 2 previous cohort
studies that had comparable effect sizes for cardio-
vascular morbidity and mortality (2,3). We were the
ﬁrst to examine the risks of BAC in categories of
severity. The increased risks were mainly associated
with severe BAC, which was only present in 1.2% of
the subcohort.
We hypothesized that an association of BAC with
increased cardiovascular risk, which was apparently
independent of traditional risk factors, might point
to a pathophysiological mechanism that differs from
the intimal atherosclerotic process. Because BAC
could be a marker of a more generalized tendency to
TABLE 1 Associations Between BAC (Presence vs. Absence and
Severe vs. Absent) and Incident Cardiovascular Disease and Diabetes
BAC Presence
BAC Severity
Severe
HR (95% CI) p Value HR (95% CI) p Value
Composite CVD endpoint
Model 1 1.16 (0.92-1.48) 0.215 2.25 (1.29-3.94) 0.005
Model 2 1.44 (1.04-1.99) 0.030 3.54 (1.89-6.64) <0.001
Model 3 1.39 (1.00-1.93) 0.048 3.37 (1.80-6.31) <0.001
Coronary heart disease
Model 1 1.22 (0.94-1.58) 0.130 2.40 (1.34-4.29) 0.003
Model 2 1.46 (1.04-2.05) 0.028 3.50 (1.82-6.72) <0.001
Model 3 1.44 (1.02-2.01) 0.036 3.40 (1.76-6.57) <0.001
Stroke
Model 1 1.19 (0.83-1.72) 0.338 2.29 (1.13-4.63) 0.022
Model 2 1.47 (0.98-2.19) 0.059 3.21 (1.51-6.83) 0.003
Model 3 1.39 (0.92-2.08) 0.116 2.85 (1.32-6.15) 0.008
Peripheral artery disease
Model 1 0.97 (0.61-1.55) 0.912 1.59 (0.62-4.07) 0.335
Model 2 1.43 (0.80-2.58) 0.231 3.24 (1.16-9.00) 0.025
Model 3 1.37 (0.74-2.52) 0.313 2.93 (1.05-8.16) 0.040
Incident diabetes
Model 1 0.75 (0.51-1.08) 0.125 1.27 (0.58-2.78) 0.555
Model 2* 0.88 (0.58-1.33) 0.542 1.24 (0.48-3.17) 0.658
BAC ¼ breast arterial calciﬁcation; CI ¼ conﬁdence interval; CVD ¼ cardiovascular disease; HR ¼
hazard ratio; Model 1 ¼ age-adjusted; Model 2 ¼ multivariable adjusted for age, smoking, high-
density lipoprotein (HDL)/total cholesterol ratio, hypertension, physical activity, body mass index,
alcohol intake, type 2 diabetes, cardiovascular disease history, parity number, menopausal status;
Model 2* ¼ multivariable adjusted for age, body mass index, physical activity, HDL/total
cholesterol ratio and smoking; Model 3 ¼ model 2 plus pulse pressure.
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860develop medial calciﬁcation in other vascular beds,
this needs further investigation. One study in renal
patients showed that BAC was associated with
medial calciﬁcation in other arterial beds (4). It is
hypothesized that medial calciﬁcation leads to CVD
through increased arterial stiffness (5). This is sup-
ported by our data, because we found that adding
pulse pressure attenuated the associations. A limited
number of studies conducted in speciﬁc patient
groups reported increased cardiovascular risks asso-
ciated with medial calciﬁcation in other vascular
beds, comparable to those we found for severe
BAC (5).
The presence of BAC is modestly associated with
CVD, with an approximately 3-fold increased risk for
severe BAC, independent of traditional risk factors.
This indicates a possible contribution of a medial,
nonatherosclerotic pathway to CVD.*Eva J.E. Hendriks, MD
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Aortic and Aortic Valve
Disease and the Risk
for Sudden Death in
Competitive AthletesSudden deaths (SDs) in young athletes are unex-
pected, tragic, and highly visible events. Consider-
able attention has been focused on pre-participation
screening to prevent these events (1). Aortic stenosis
(AS) is known as an important cause of SD in the
young, whereas aortic dissection/rupture is a cata-
strophic condition not usually associated with demise
early in life (2,3). The role of these diseases in athletic
ﬁeld deaths and their identiﬁcation by standard
routine pre-participation screening (e.g., history and
physical examination in the United States) is incom-
pletely understood.
The U.S. National Registry of Sudden Death in
Athletes, a forensic and clinical database that collects
SDs of competitive athletes under 40 years of age (4),
